Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
NCT07200869 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-10-01
Summary
This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.
Conditions
- Sickle Cell Disease
- Vaso-occlusive Crisis
Interventions
- OTHER
-
No intervention
retrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2027-10-31
- Completion
- 2027-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease
NCT01501643 ·Status: TERMINATED ·Phase: NA
-
Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study.
NCT05203991 ·Status: COMPLETED
-
Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
NCT05371184 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
NCT01482091 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 ·Status: COMPLETED
-
Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease
NCT01033227 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Neutrophil Extracellular Traps and Sickle Cell Disease
NCT02004808 ·Status: UNKNOWN
-
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
NCT06612268 ·Status: RECRUITING ·Phase: PHASE3
-
L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)
NCT04852172 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
NCT06699849 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
NCT01522196 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of Warmed Saline in Vaso-occlusive Episodes
NCT02316366 ·Status: COMPLETED ·Phase: NA
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Blood Platelets in Sickle Cell Disease
NCT00226083 ·Status: WITHDRAWN
-
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
NCT01800526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease
NCT05748717 ·Status: RECRUITING
-
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
NCT00004408 ·Status: COMPLETED ·Phase: PHASE3
-
The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center
NCT03903289 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA
-
L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity
NCT05470998 ·Status: COMPLETED ·Phase: PHASE3
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
NCT01197417 ·Status: COMPLETED ·Phase: PHASE2/PHASE3